Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Drug Recalls For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… Factive (gemifloxacin mesylate) Tablets, 320 mg, GeneSoft NDA 21-158/S1 7/25/03 8/15/03 8/15/03 Factive (gemifloxacin mesylate) Tablets, 320 mg, LG Life Sciences, Ltd NDA 21-158 FACTIVE (gemifloxacin mesylate) Tablets, Parexel International, Labeling Revision FACTIVE (gemifloxacin mesylate) Tablets, Parexel International, Labeling Revision | Factive (gemifloxacin mesylate) Tablets, Oscient Pharma, Labeling Revision | Factive (gemifloxacin mesylate) Tablets, Oscient Pharma, New Dosage Regimen | Factive (gemifloxacin) Tablets, Oscient Pharma, Labeling Revision | Factive (gemifloxacin mesylate) Tablets, Oscient Pharmaceuticals Corp., Labeling Revision | Factive (gemifloxacin mesylate) Tablets, Oscient Pharmaceuticals Corp., Package Change ^ FDA's latest approval appears at the bottom of this list. ^   A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | Pharma Company News © 2008 Betterchem.com